Benefits of probabilistic sensitivity analysis – a review of NICE decisions

OBJECTIVE: Since 2004, the National Institute of Health and Clinical Excellence (NICE) has required manufacturers to conduct a probabilistic sensitivity analysis (PSA) in their technology appraisals. The objective of this review is to assess the cost-effectiveness of different technology appraisals...

Descripción completa

Detalles Bibliográficos
Autores principales: Adalsteinsson, Erpur, Toumi, Mondher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865759/
https://www.ncbi.nlm.nih.gov/pubmed/27226828
http://dx.doi.org/10.3402/jmahp.v1i0.21240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865759/
https://www.ncbi.nlm.nih.gov/pubmed/27226828
http://dx.doi.org/10.3402/jmahp.v1i0.21240

Ejemplares similares